Showing results (61-70 of 247) with videos related to
Sort By:
Pageof 25
JAMA Psychiatry|October 2, 2014
Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophreniaMartin Gevonden, Jan Booij, Wim van den Brink, et al.Brain and Behavior|September 6, 2012
Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging researchCleo L Crunelle, Dick J Veltman, Jan Booij, et al.BMJ Open|February 10, 2012
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort studyZuzana Walker, Ian McKeith, Joanne Rodda, et al.European Journal of Medicinal Chemistry|October 18, 2011
Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptorRana Al Hussainy, Joost Verbeek, Dion van der Born, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2011
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese ratsElsmarieke van de Giessen, Kora de Bruin, Susanne E la Fleur, et al.Dementia and Geriatric Cognitive Disorders|November 19, 2011
Early and presenting symptoms of dementia with lewy bodiesEirik Auning, Arvid Rongve, Tormod Fladby, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 14, 2011
The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge testBreg Braak, Jan Booij, Tamira K Klooker, et al.EJNMMI Research|July 26, 2019
Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [<sup>123</sup>I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's diseaseSven R Suwijn, Constant V M Verschuur, Marleen A Slim, et al.Pharmacogenetics and Genomics|November 7, 2008
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorderHenricus G Ruhé, Wendy Ooteman, Jan Booij, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 25, 2015
Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy BodiesFrançoise J Siepel, Ingvild Dalen, Renate Grüner, et al.Pageof 25